Anish John
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anish John
Anish John was last confirmed as CFO at Insight Molecular Diagnostics Inc. (IMDX) in a filing dated May 19, 2023. Insight Molecular Diagnostics Inc. reported in an 8-K filed August 10, 2022 that Anish John was appointed Chief Financial Officer, effective August 8, 2022. The proxy statement of Insight Molecular Diagnostics Inc. reports total compensation of $449,161 for Anish John in fiscal 2023, including a base salary of $147,138. Disclosed compensation is on record for 2 fiscal years.
“Effective August 8, 2022, the Board of Directors of the Company appointed Gisela Paulsen to the position of President and Chief Operating Officer and Anish John to the position of Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-05-19
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Insight Molecular Diagnostics Inc. (IMDX) | Former Chief Financial Officer | $147,138 | $449,161 |
| 2022 | Insight Molecular Diagnostics Inc. (IMDX) | Former Chief Financial Officer | $285,962 | $738,162 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.